Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhong-Zhe Lin

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|December 10, 2021
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular CarcinomaChing-Tso Chen, Tsung-Hao Liu, Yu-Yun Shao, et al.
International Journal of Hepatology|May 22, 2013
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastasesYi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, et al.
Oncology|October 12, 2011
High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapyYu-Yun Shao, Zhong-Zhe Lin, Te-Jung Chen, et al.
Mindfulness|May 10, 2021
The Short- and Long-term Causal Relationships Between Self-compassion, Trait Mindfulness, Caregiver Stress, and Depressive Symptoms in Family Caregivers of Patients with Lung CancerChia-Chen Hsieh, Zhong-Zhe Lin, Chao-Chi Ho, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancerYu-Yun Shao, Wen-Yi Shau, Zhong-Zhe Lin, et al.
Journal of Hepatology|April 27, 2010
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinomaChih-Hung Hsu, Ying-Chun Shen, Zhong-Zhe Lin, et al.
Oncology|May 3, 2013
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiformePei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2019
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYu-Yun Shao, Tsung-Hao Liu, Chiun Hsu, et al.
The Oncologist|July 25, 2012
Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based studyZhong-Zhe Lin, Wen-Yi Shau, Yu-Yun Shao, et al.
Expert Review of Gastroenterology & Hepatology|May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|December 10, 2021
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular CarcinomaChing-Tso Chen, Tsung-Hao Liu, Yu-Yun Shao, et al.
International Journal of Hepatology|May 22, 2013
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastasesYi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, et al.
Oncology|October 12, 2011
High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapyYu-Yun Shao, Zhong-Zhe Lin, Te-Jung Chen, et al.
Mindfulness|May 10, 2021
The Short- and Long-term Causal Relationships Between Self-compassion, Trait Mindfulness, Caregiver Stress, and Depressive Symptoms in Family Caregivers of Patients with Lung CancerChia-Chen Hsieh, Zhong-Zhe Lin, Chao-Chi Ho, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancerYu-Yun Shao, Wen-Yi Shau, Zhong-Zhe Lin, et al.
Journal of Hepatology|April 27, 2010
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinomaChih-Hung Hsu, Ying-Chun Shen, Zhong-Zhe Lin, et al.
Oncology|May 3, 2013
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiformePei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2019
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYu-Yun Shao, Tsung-Hao Liu, Chiun Hsu, et al.
The Oncologist|July 25, 2012
Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based studyZhong-Zhe Lin, Wen-Yi Shau, Yu-Yun Shao, et al.
Expert Review of Gastroenterology & Hepatology|May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.
Pageof 8